| Primary |
| Attention Deficit/hyperactivity Disorder |
66.4% |
| Chorea |
5.3% |
| Asthma |
2.7% |
| Dermatitis Atopic |
2.7% |
| Hypersensitivity |
2.7% |
| Sleep Disorder |
2.7% |
| Coordination Abnormal |
1.8% |
| Depression |
1.8% |
| Pain |
1.8% |
| Product Used For Unknown Indication |
1.8% |
| Prophylaxis |
1.8% |
| Pyrexia |
1.8% |
| Schizophrenia |
1.8% |
| Aggression |
0.9% |
| Autism Spectrum Disorder |
0.9% |
| Insomnia |
0.9% |
| Psychomotor Hyperactivity |
0.9% |
| Rhinitis Allergic |
0.9% |
| Tic |
0.9% |
|
| Suicidal Ideation |
14.1% |
| Hepatic Function Abnormal |
9.4% |
| Palpitations |
7.8% |
| Suicide Attempt |
7.8% |
| Tachycardia |
7.8% |
| Weight Decreased |
7.8% |
| Appendicitis |
4.7% |
| Loss Of Consciousness |
4.7% |
| Abdominal Pain Upper |
3.1% |
| Aggression |
3.1% |
| Completed Suicide |
3.1% |
| Head Injury |
3.1% |
| Hypertransaminasaemia |
3.1% |
| Hypothermia |
3.1% |
| Jaundice |
3.1% |
| Peripheral Coldness |
3.1% |
| Speech Disorder |
3.1% |
| Syncope |
3.1% |
| Tremor |
3.1% |
| Arrhythmia |
1.6% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
64.1% |
| Dermatitis Atopic |
9.8% |
| Asthma |
8.7% |
| Pyrexia |
6.5% |
| Rhinitis Allergic |
3.3% |
| Hypersensitivity |
2.2% |
| Insomnia |
2.2% |
| Abnormal Behaviour |
1.1% |
| Autism Spectrum Disorder |
1.1% |
| Depression |
1.1% |
|
| Hepatic Function Abnormal |
23.7% |
| Suicidal Ideation |
15.8% |
| Thyroid Mass |
7.9% |
| Palpitations |
5.3% |
| Syncope |
5.3% |
| Toxicity To Various Agents |
5.3% |
| Weight Decreased |
5.3% |
| Completed Suicide |
3.9% |
| Infection |
3.9% |
| Myocardial Infarction |
3.9% |
| Abdominal Pain Upper |
2.6% |
| Loss Of Consciousness |
2.6% |
| Somnolence |
2.6% |
| Syncope Vasovagal |
2.6% |
| White Blood Cell Count Decreased |
2.6% |
| Attention Deficit/hyperactivity Disorder |
1.3% |
| Cardiac Arrest |
1.3% |
| Cardio-respiratory Arrest |
1.3% |
| Chest Pain |
1.3% |
| Dengue Fever |
1.3% |
|
| Concomitant |
| Attention Deficit/hyperactivity Disorder |
44.4% |
| Bipolar Disorder |
11.1% |
| Growth Hormone Deficiency |
11.1% |
| Hypoparathyroidism |
11.1% |
| Insomnia |
11.1% |
| Psychotic Disorder |
11.1% |
|
| Acute Myeloid Leukaemia |
25.0% |
| Eosinophilic Pneumonia |
12.5% |
| Musculoskeletal Stiffness |
12.5% |
| Neoplasm Recurrence |
12.5% |
| Posturing |
12.5% |
| Tongue Disorder |
12.5% |
| Vomiting |
12.5% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Attention Deficit/hyperactivity Disorder |
25.0% |
| Obsessive-compulsive Disorder |
25.0% |
|
| Condition Aggravated |
50.0% |
| Drug Interaction |
50.0% |
|
